{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:11:16Z","timestamp":1758039076128,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ad.2016.12.008","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T06:01:00Z","timestamp":1487224860000},"page":"365-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["FR-\u00bfSon los nuevos agentes antivirales de acci\u00f3n directa un tratamiento eficaz para las manifestaciones cut\u00e1neas de la hepatitis C?"],"prefix":"10.1016","volume":"108","author":[{"given":"D.","family":"Morgado-Carrasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Fust\u00e0-Novell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giavedoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.12.008_bib0030","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: A meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ad.2016.12.008_bib0035","article-title":"Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals","author":"Bonacci","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ad.2016.12.008_bib0040","unstructured":"AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. [consultado 23 Oct 2016] Disponible en: http:\/\/www.hcvguidelines.org"},{"key":"10.1016\/j.ad.2016.12.008_bib0045","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1038\/ctg.2016.37","article-title":"Successful treatment of hepatitis C virus-associated oral lichen planus by interferon-free therapy with direct-acting antivirals","volume":"7","author":"Nagao","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.ad.2016.12.008_bib0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamadermatol.2016.3036","article-title":"Resolution of porphyria cutanea tarda in patients with hepatitis C following ledipasvir-sofosbuvir combination therapy","volume":"152","author":"Tong","year":"2016","journal-title":"JAMA Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:06:19Z","timestamp":1757552779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017300467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0001731017300467"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.008","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FR-\u00bfSon los nuevos agentes antivirales de acci\u00f3n directa un tratamiento eficaz para las manifestaciones cut\u00e1neas de la hepatitis C?","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}